Seres to use Emulate's Intestine-Chip

Microbiome company Seres Therapeutics Inc. (NASDAQ:MCRB) and organ-on-chip play Emulate Inc. (Boston, Mass.) partnered to use Emulate's Intestine-Chip platform to identify bacteria compositions with therapeutic potential. ...